New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 14, 2013
10:57 EDTNUSNu Skin complaints as of Feb. 2013 posted on FTC site
On its website, the Federal Trade Commission stated that its Freedom of Information Act office often receives repeated requests for specific FTC documents and company records. The FTC posted a link to a PDF document summarizing complaints related to Nu Skin (NUS) as of Feb. 2013. Reference Link
News For NUS From The Last 14 Days
Check below for free stories on NUS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 18, 2014
09:54 EDTNUSNu Skin mentioned cautiously by Bronte Capital
Reference Link
August 13, 2014
06:39 EDTNUSNu Skin volatility flat as shares near15-month low
Nu Skin August call option implied volatility is at 45, September and December is at 44; compared to its 26-week average of 47 according to Track Data, suggesting decreasing price movement.
August 7, 2014
10:00 EDTNUSOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:08 EDTNUSNu Skin orice target lowered to $70 from $110 at Deutsche Bank
Deutsche Bank lowered its price target for Nu Skin shares to $70 saying the regulatory overhang "continue to wreak havoc on the company’s important China business." The firm, however, says comparisons ease next year and that inventory can be worked down or written off. Deutsche keeps a Buy rating on Nu Skin following yesterday's Q2 results. Note the stock was downgraded this morning at JPMorgan to Neutral.
05:48 EDTNUSNu Skin downgraded to Neutral from Overweight at JPMorgan
JPMorgan downgraded Nu Skin to Neutral saying the underlying business is weaker than it expected with little visibility following the company's Q2 results. The firm cut its price target for shares in half to $50 from $100. Nu Skin closed yesterday down $11.40 to $46.52 after reporting Q2 results.
August 6, 2014
15:14 EDTNUSNu Skin value still compelling, says Sidoti
Subscribe for More Information
13:50 EDTNUSNu Skin price target lowered to $65 from $105 at Wedbush
Subscribe for More Information
12:12 EDTNUSOn The Fly: Midday Wrap
Subscribe for More Information
11:44 EDTNUSNu Skin says China investigation resulted in no business model changes
Subscribe for More Information
11:30 EDTNUSNu Skin says China sales leaders 'down substantially' from last year
Nu Skin is speaking on its earnings conference call.
11:22 EDTNUSNu Skin says guidance reflects Q2 being 'low watermark' in China
Subscribe for More Information
11:20 EDTNUSNu Skin August volatility elevated on less than expected guidance
Nu Skin August weekly call option implied volatility is at 97, August is at 65, September is at 58, December is at 50; compared to its 26-week average of 47 according to Track Data, suggesting large near term price risk on less than expected guidance.
11:11 EDTNUSNu Skin says business 'firming' in China, expects trends to continue
Nu Skin is speaking on its earnings conference call.
09:13 EDTNUSOn The Fly: Pre-market Movers
HIGHER: Fox class A shares (FOXA), up 5.9% after withdrawing proposal to acquire Time Warner (TWX), announcing $6B share repurchase program, reporting quarterly results... MannKind (MNKD), up 1.6% after entering a supply agreement with Amphastar Pharmaceuticals (AMPH)... Criteo (CRTO), up 11.5% after upgraded at Goldman following its better than expected Q2 earnings report. LOWER: Time Warner (TWX), down 13% after earnings, maintaining guidance, bid dropped by Fox... Sprint (S), down 16.5% after naming Marcelo Claure as president and CEO, reportedly dropping pursuit of T-Mobile (TMUS). T-Mobile shares also down 8.5%... Groupon (GRPN), down 18%, downgraded at Wunderlich after the company reported lower than expected Q3 results... Walgreen (WAG), down 15.7% after exercises option to acquire remaining 55% of Alliance Boots, says it will not pursue inversion as part of deal... Shire (SHPG), down 6% after Walgreen announced it would stay located in Chicago and Bloomberg last night reported that the Treasury Department is exploring ways to bypass Congress in an attempt to curb corporate inversions... Cytori Therapeutics (CYTX), down 33% after announcing that it has placed enrollment in the ATHENA and ATHENA II trials on clinical hold. UP AFTER EARNINGS: Enphase Energy (ENPH), up 20%... AOL (AOL), up 5%. DOWN AFTER EARNINGS: Nu Skin (NUS), down 8.5%... Rocket Fuel (FUEL), down 27%... Cognizant (CTSH), down 13%... First Solar (FSLR), down 2.5%... Globus Medical (GMED), down 17%.
07:36 EDTNUSNu Skin: Cessation in China marketing raises difficult comparisons in 2H14
Subscribe for More Information
07:35 EDTNUSNu Skin sees Q4 EPS $1.00-$1.05; Sees Q4 revenue $650M-$670M
Subscribe for More Information
07:35 EDTNUSNu Skin sees Q3 EPS 90c-95c, consensus $1.68
Sees Q3 revenue $620M-$640M, consensus $847.46M
07:34 EDTNUSNu Skin amends Q1 results that negatively impacted net income by $9.4M
The company determined to amend its quarterly report on Form 10-Q and restate its consolidated financial statements for the quarter ended March 31, 2014 to include a $21M charge to Other Income to reflect a hyper-inflationary adjustment for Venezuela, and $7M of income related to a tax rebate for the company's China headquarters. These changes, net of tax, negatively impacted net income for the three-month period ended March 31, 2014 by approximately $9.4M, but had no effect on cash flow. The company's consolidated statements of income for the six-month period ended June 30, 2014 reflect this correction of first-quarter results.
07:32 EDTNUSNu Skin reports Q2 EPS excl. items $1.13, consensus $1.27
Reports Q2 revenue $650M, consensus $709.03M

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use